Viewing Study NCT01664494


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-02-02 @ 8:12 AM
Study NCT ID: NCT01664494
Status: COMPLETED
Last Update Posted: 2016-05-02
First Post: 2012-08-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer, Colon Cancer in the Adjuvant Setting, Advanced Gastric Cancer or Breast Cancer
Sponsor: Hoffmann-La Roche
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer, Colorectal Cancer, Gastric Cancer View
Keywords: